Covered recipient · General Payments record
TED EDWARDS
Allopathic & Osteopathic Physicians Pain Medicine Interventional Pain Medicine
General Payments · PY2018–2024
$2,624.91
- Reported across 130 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $615.06 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EISAI INC. | $191.04 | 7 |
| Neurocrine BioSciences, Inc. | $121.54 | 4 |
| PFIZER INC. | $100.29 | 3 |
| ABBVIE INC. | $68.08 | 3 |
| Lilly USA, LLC | $51.58 | 3 |
| SK Life Science, Inc. | $35.34 | 2 |
| ARGENX US, INC. | $27.47 | 1 |
| SCILEX PHARMACEUTICALS INC. | $19.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.35 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103678299 | CMS |
| ABBVIE INC. | $22.09 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103678301 | CMS |
| ABBVIE INC. | $24.64 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103678303 | CMS |
| ARGENX US, INC. | $27.47 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142105335 | CMS |
| Eisai Inc. | $31.16 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110785015 | CMS |
| Eisai Inc. | $29.12 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110785019 | CMS |
| Eisai Inc. | $24.84 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110785013 | CMS |
| Eisai Inc. | $19.47 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110785021 | CMS |
| Eisai Inc. | $28.35 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110785017 | CMS |
| Eisai Inc. | $30.01 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110785011 | CMS |
| Eisai Inc. | $28.09 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110785023 | CMS |
| Lilly USA, LLC | $17.85 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135436257 | CMS |
| Lilly USA, LLC | $16.84 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135455627 | CMS |
| Lilly USA, LLC | $16.89 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135436259 | CMS |
| Neurocrine Biosciences, Inc. | $30.29 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150825448 | CMS |
| Neurocrine Biosciences, Inc. | $27.98 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150831212 | CMS |
| Neurocrine Biosciences, Inc. | $33.87 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150820116 | CMS |
| Neurocrine Biosciences, Inc. | $29.40 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150827256 | CMS |
| PFIZER INC. | $69.38 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131813492 | CMS |
| PFIZER INC. | $14.12 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131981457 | CMS |
| PFIZER INC. | $16.79 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131105750 | CMS |
| SCILEX PHARMACEUTICALS INC. | $19.72 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136215115 | CMS |
| SK Life Science, Inc. | $19.29 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154134297 | CMS |
| SK Life Science, Inc. | $16.05 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154134433 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.